U.S. Markets open in 2 hrs 39 mins

Amedisys Inc (AMED) Files 10-K for the Fiscal Year Ended on December 31, 2017

- By insider

Amedisys Inc (AMED) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Amedisys Inc is a provider of low-cost home health services to the chronic, co-morbid, aging American population. The Company's operations include servicing patients through its segments home health and hospice. Amedisys Inc has a market cap of $2.01 billion; its shares were traded at around $59.21 with a P/E ratio of 47.37 and P/S ratio of 1.33.


For the last quarter Amedisys Inc reported a revenue of $404.2 million, compared with the revenue of $366.3 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $1.5 billion, an increase of 6.7% from last year. For the last five years Amedisys Inc had an average revenue growth rate of 2.3% a year.

The reported diluted earnings per share was 88 cents for the year, a decline of 20% from the previous year. The Amedisys Inc had an operating margin of 5.12%, compared with the operating margin of 3.99% a year before. The 10-year historical median operating margin of Amedisys Inc is 3.00%. The profitability rank of the company is 4 (out of 10).

At the end of the fiscal year, Amedisys Inc has the cash and cash equivalents of $86.4 million, compared with $30.2 million in the previous year. The long term debt was $78.2 million, compared with $87.8 million in the previous year. The interest coverage to the debt is at a comfortable level of 15.6. Amedisys Inc has a financial strength rank of 7 (out of 10).

At the current stock price of $59.21, Amedisys Inc is traded at 71.2% premium to its historical median P/S valuation band of $34.59. The P/S ratio of the stock is 1.33, while the historical median P/S ratio is 0.79. The stock gained 22.79% during the past 12 months.

For the complete 20-year historical financial data of AMED, click here.

This article first appeared on GuruFocus.